RNAM
Avidity Biosciences Inc
NASDAQ · Healthcare · Biotechnology · US
$72.86
+0.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.94x
- Price / sales
- 534.98x
- Price / cash flow
- -15.43x
Enterprise value
- Enterprise value
- $8.4B
- EV / sales
- 449.55x
- EV / EBITDA
- -11.37x
- EV / EBIT
- -11.30x
- Market cap
- $10.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025